Total submissions: 15
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000120388 | SCV000150034 | benign | not specified | 2018-02-28 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV001084447 | SCV000166671 | benign | Familial cancer of breast; Fanconi anemia complementation group J | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000116125 | SCV000183881 | benign | Hereditary cancer-predisposing syndrome | 2019-05-07 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Counsyl | RCV000409336 | SCV000489881 | benign | Fanconi anemia complementation group J | 2016-07-11 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000410488 | SCV000489882 | benign | Ovarian neoplasm | 2016-07-11 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000514890 | SCV000600893 | benign | not provided | 2022-03-29 | criteria provided, single submitter | clinical testing | |
Center for Pediatric Genomic Medicine, |
RCV000514890 | SCV000610616 | likely benign | not provided | 2017-05-11 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000116125 | SCV000689260 | benign | Hereditary cancer-predisposing syndrome | 2017-11-12 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000409336 | SCV001283866 | benign | Fanconi anemia complementation group J | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
National Health Laboratory Service, |
RCV002225333 | SCV002505037 | benign | Hereditary breast ovarian cancer syndrome | 2022-04-19 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV000120388 | SCV002760982 | benign | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing | |
KCCC/NGS Laboratory, |
RCV003315647 | SCV004016921 | benign | Familial cancer of breast | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV003315647 | SCV004019482 | likely benign | Familial cancer of breast | 2023-03-02 | criteria provided, single submitter | clinical testing | This variant is considered likely benign. This variant has been observed at a population frequency that is significantly greater than expected given the associated disease prevalence and penetrance. |
ITMI | RCV000120388 | SCV000084540 | not provided | not specified | 2013-09-19 | no assertion provided | reference population | |
Department of Pathology and Laboratory Medicine, |
RCV000514890 | SCV001548876 | likely benign | not provided | no assertion criteria provided | clinical testing | The BRIP1 p.His478Arg variant was identified in 1 of 2520 proband chromosomes (frequency: 0.0004) from individuals or families with Lynch syndrome (Yurgelun 2015). The variant was also identified in dbSNP (ID: rs45501097) as With Uncertain significance allele, ClinVar (classified as benign by Invitae, Counsyl; classified as likely benign by GeneDx; classified as uncertain significance by Ambry Genetics), Zhejiang Colon Cancer Database, databases. The variant was not identified in the Cosmic or MutDB databases. The variant was identified in control databases in 493 (8 homozygous) of 270132 chromosomes at a frequency of 0.002 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Consortium Feb 27, 2017). The variant was identified in the following populations at a frequency greater than 1%: South Asian in 480 of 29928 chromosomes (freq: 0.016). The p.His478 residue is not conserved in mammals and four out of five computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) do not suggest a high likelihood of impact to the protein; however, this information is not predictive enough to rule out pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, HumanSpliceFinder) do not predict a difference in splicing. The variant is located with the DNA helicase (DNA repair), Rad3 type functional domain the clinical significance of which is not known. In summary, based on the above information, the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as likely benign. |